Clinical trial

Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery…

NCT00462631 · Heart Centre Rotenburg, Other · Completed

Key facts

NCT number NCT00462631
Title Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients
Official title Paclitaxel-Eluting Balloon Angioplasty and Cobalt-Chromium Stents Versus Conventional Angioplasty and Paclitaxel-Eluting Stents in the Treatment of Native Coronary Artery Stenoses of Diabetic Patients
Acronym PEPCAD IV
Lead sponsor Heart Centre Rotenburg, Other
Collaborators B. Braun Medical SA Industry
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Coronary Stenosis, Diabetes Mellitus
Intervention type Device
Interventions Paclitaxel Eluting Balloon, paclitaxel eluting stent, bare metal stent
Enrollment 84
Start date May 1, 2007
Primary completion Sep 1, 2011
Completion Feb 1, 2016
First posted Apr 19, 2007
Last update posted Feb 19, 2016
Countries Malaysia

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies